Company / Operating Margin
Corbus Pharmaceuticals Holdings, Inc. Operating Margin History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-6350.1%
FY2022
5-year range
-6350.1% / -213.3%
FY2018-FY2022
Trend
-103.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -213.3% to -6350.1% over the past 2 years.
Based on SEC 10-K filings.
-6350.1% in FY2022 with a 5-year CAGR of -4984.6%.
Declined from -213.3% to -6350.1% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -5173.3pp
- 5-Year Change
- -4984.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, operating margin decreased 103.6% year-over-year.
- Peak operating margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -6350.1% | -103.6% |
| FY2021 | -3119.2% | -1362.1% |
| FY2020 | -213.3% | +81.9% |
| FY2019 | -1176.8% | +11.8% |
| FY2018 | -1334.4% | +2.3% |
| FY2017 | -1365.5% | +0.0% |
| FY2016 | -1365.5% | -234.5% |
| FY2015 | -408.3% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026